A rechargeable, wireless, sacral neuromodulation (SNM) implant, made by Axonics Modulation Technologies Inc., has been recommended for use as a treatment for overactive bladder in England’s National Health Service by the health technology assessment (HTA) body, NICE.
The Axonics r-SNM system will last longer than the standard non-rechargeable system, resulting in a cost saving for the NHS after six years of use and fewer replacement surgeries, according...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?